SON-1210

N/A

Report date: 2024/01/29 17:45:42

Base Information

Drug NameSON-1210
Drug Alias NameSON-1210IL12-FHAB-IL15
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-12 modulatorsInterleukin-15 modulators
TargetsInterleukin-12Interleukin-15
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSonnet Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSonnet Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A